Spyre Therapeutics
SYRE
#2075
Rank
โ‚ฌ8.09 B
Marketcap
85,21ย โ‚ฌ
Share price
-4.26%
Change (1 day)
304.50%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): -2,44ย โ‚ฌ

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -2,56ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,87ย โ‚ฌ an increase over its 2024 EPS that were of -3,40ย โ‚ฌ.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,44ย โ‚ฌ30.14%
2025-1,87ย โ‚ฌ-44.82%
2024-3,40ย โ‚ฌ